Evidence map›Paper›PMID 38681351›Full record

ArticleCureus2024

Successful Treatment of Refractory Trichodynia With Onabotulinumtoxin-A.

Faris A Alhomida, Sarah Alkhezzi, Rasha Alshammari, Bushra S Alasmari, Dalal A AlDosari, Monira AlNasser, Asem Almesfer, Saad AlSaadan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Faris A AlhomidaDermatology, King Fahad Medical City, Riyadh, SAU.
Sarah AlkhezziDermatology, King Fahad Medical City, Riyadh, SAU.
Rasha AlshammariDermatology, King Fahad Medical City, Riyadh, SAU.
Bushra S AlasmariDermatology, King Saud Bin Abdulaziz University for Health Sciences College of Medicine, Riyadh, SAU.
Dalal A AlDosariDermatology, King Fahad Medical City, Riyadh, SAU.
Monira AlNasserDermatology, King Fahad Medical City, Riyadh, SAU.
Asem AlmesferDermatology, King Fahad Medical City, Riyadh, SAU.
Saad AlSaadanDermatology, King Fahad Medical City, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichodynia is a common symptom, which is characterized by a painful, burning or stinging sensation of the scalp, often in patients presenting with hair loss. It is typically associated with co-morbid psychiatric conditions and remains challenging to treat, with no Food and Drug Administration (FDA) treatments currently available. We herein report the successful use of off-label onabotulinumtoxin-A in treating a patient with trichodynia who has failed conventional therapies.

Indexed as

botoxbotulinum toxinhair lossoff-labelpainprocedurepsychiatric co-morbiditiesscalp dysesthesiatreatmenttrichodynia

Identifiers

PMID38681351
PMCPMC11046174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.